Expression of the long non-coding RNA HOTAIR correlates with disease progression in bladder cancer and is contained in bladder cancer patient urinary exosomes

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Berrondo, Claudia ^a   Flax, Jonathan ^a   Kucherov, Victor ^b   Siebert, Aisha ^b   Osinski, Thomas ^b   Rosenberg, Alex ^a   Fucile, Christopher ^a   Richheimer, Samuel ^a   Beckham, Carla J ^a  

^a STRONG MEMORIAL HOSPITAL   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERSTITIAL COLLAGENASE; LAMININ; LAMININ BETA3; LAMININ GAMMA2; LONG NON CODING RNA HOX TRANSCRIPT ANTISENSE RNA; LONG UNTRANSLATED RNA; PROTEIN ZO1; RNA; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR ZEB1; TUMOR MARKER; UNCLASSIFIED DRUG; HOTAIR LONG UNTRANSLATED RNA, HUMAN; MICRORNA; SMALL INTERFERING RNA;

ADULT; ARTICLE; CANCER CELL LINE; CANCER GRADING; CANCER GROWTH; CANCER PROGNOSIS; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTECTOMY; DISEASE COURSE; EPITHELIAL MESENCHYMAL TRANSITION; EXOSOME; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LAMB3 GENE; LAMC2 GENE; MMP1 GENE; MUSCLE INVASIVE BLADDER CANCER; PROTEIN EXPRESSION; RNA SEQUENCE; SNAI1 GENE; TWIST1 GENE; URINALYSIS; ZEB1 GENE; ZO1 GENE; BLADDER TUMOR; CELL LINE; CELL MOTION; ELECTRON MICROSCOPY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; PHYSIOLOGY; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE; CELL MOVEMENT; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; EXOSOMES; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; MICRORNAS; MICROSCOPY, ELECTRON; RNA, LONG NONCODING; RNA, SMALL INTERFERING; URINARY BLADDER NEOPLASMS;

EID: 84958214273     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0147236     Document Type: Article

References (92)

1. Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet. 2014; 15: 7-21. doi: 10.1038/nrg3606 PMID: 24296535
2. Fatima R, Akhade VS, Pal D, Rao SM. Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets. Mol Cell Ther. 2015; 3: 5. doi: 10.1186/s40591-015-0042-6 PMID: 26082843
3. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010; 464: 1071-1076. doi:10.1038/nature08975 PMID: 20393566
4. Doose G, Haake A, Bernhart SH, López C, Duggimpudi S, Wojciech F, et al. MINCR is a MYC-induced lncRNA able to modulate MYC's transcriptional network in Burkitt lymphoma cells. Proc Natl Acad Sci U S A. 2015; 112: E5261-70.
5. Sun M, Nie F-Q, Wang Z-X, De W. Involvement of lncRNA dysregulation in gastric cancer. Histol Histopathol. 2016; 31: 33-9. doi: 10.14670/HH-11-655 PMID: 26302456
6. Huang Y, Zheng Y, Jia L, Li W. Long Noncoding RNA H19 Promotes Osteoblast Differentiation Via TGF-β1/Smad3/HDAC Signaling Pathway by Deriving miR-675. Stem Cells. 2015; doi: 10.1002/stem. 2225
7. Iyer MK, Niknafs YS, Malik R, Singhal U, Sahu A, Hosono Y, et al. The landscape of long noncoding RNAs in the human transcriptome. Nat Genet. 2015; 47: 199-208. doi: 10.1038/ng.3192 PMID: 25599403
8. Peng P, Yan Y, Keng S. Exosomes in the ascites of ovarian cancer patients: origin and effects on antitumor immunity. Oncol Rep. 2011; 25: 749-62. doi: 10.3892/or.2010.1119 PMID: 21181093
9. Navabi H, Croston D, Hobot J, Clayton A, Zitvogel L, Jasani B, et al. Preparation of human ovarian cancer ascites-derived exosomes for a clinical trial. Blood Cells Mol Dis. 35: 149-52. doi: 10.1016/j.bcmd. 2005.06.008 PMID: 16061407
10. Runz S, Keller S, Rupp C, Stoeck A, Issa Y, Koensgen D, et al. Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM. Gynecol Oncol. 2007; 107: 563-71. doi:10.1016/j.ygyno.2007.08.064 PMID: 17900673
11. Moldovan L, Batte K, Wang Y, Wisler J, Piper M. Analyzing the circulating microRNAs in exosomes/ extracellular vesicles from serum or plasma by qRT-PCR. Methods Mol Biol. 2013; 1024: 129-45. doi: 10.1007/978-1-62703-453-1-10 PMID: 23719947
12. Caivano A, Laurenzana I, De Luca L, La Rocca F, Simeon V, Trino S, et al. High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders. Tumour Biol. 2015; doi: 10.1007/s13277-015-3741-3
13. Lewis JM, Heineck DP, Heller MJ. Detecting cancer biomarkers in blood: challenges for new molecular diagnostic and point-of-care tests using cell-free nucleic acids. Expert Rev Mol Diagn. 2015; 15: 1187-200. PMID: 26189641
14. Melo SA, Luecke LB, Kahlert C, Fernandez AF, Gammon ST, Kaye J, et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature. 2015; 523: 177-82. doi: 10.1038/nature14581 PMID: 26106858
15. Ostenfeld MS, Jeppesen DK, Laurberg JR, Boysen AT, Bramsen JB, Primdal-Bengtson B, et al. Cellular disposal of miR23b by RAB27-dependent exosome release is linked to acquisition of metastatic properties. Cancer Res. 2014; 74: 5758-71. doi: 10.1158/0008-5472.CAN-13-3512 PMID: 25261234
16. Takahashi K, Yan IK, Kogure T, Haga H, Patel T. Extracellular vesicle-mediated transfer of long noncoding RNA ROR modulates chemosensitivity in human hepatocellular cancer. FEBS Open Bio. 2014; 4: 458-467. doi: 10.1016/j.fob.2014.04.007 PMID: 24918061
17. Villarroya-Beltri C, Gutierrez-Vazquez C, Sanchez-Cabo F, Perez-Hernandez D, Vazquez J, Martin-Cofreces N, et al. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat Commun. 2013; 4: 2980. doi: 10.1038/ncomms3980 PMID: 24356509
18. Gezer U, Ozgur E, Cetinkaya M, Isin M, Dalay N. Long non-coding RNAs with low expression levels in cells are enriched in secreted exosomes. Cell Biol Int. 2014; 38: 1076-1079. doi: 10.1002/cbin.10301 PMID: 24798520
19. Batagov AO, Kuznetsov VA, Kurochkin IV. Identification of nucleotide patterns enriched in secreted RNAs as putative cis-acting elements targeting them to exosome nano-vesicles. BMC Genomics. 2011; 12 Suppl 3: S18. doi: 10.1186/1471-2164-12-S3-S18 PMID: 22369587
20. Kogure T, Yan IK, Lin WL, Patel T. Extracellular Vesicle-Mediated Transfer of a Novel Long Noncoding RNA TUC339: A Mechanism of Intercellular Signaling in Human Hepatocellular Cancer. Genes Cancer. 2013; 4: 261-272. doi: 10.1177/1947601913499020 PMID: 24167654
21. Cha DJ, Franklin JL, Dou Y, Liu Q, Higginbotham JN, Demory Beckler M, et al. KRAS-dependent sorting of miRNA to exosomes. Elife. 2015; 4: e07197. doi: 10.7554/eLife.07197 PMID: 26132860
22. Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012; 22: 1775-1789. doi: 10.1101/gr.132159.111 PMID: 22955988
23. Skog J, Würdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008; 10: 1470-1476. doi: 10.1038/ncb1800 PMID: 19011622
24. Thakur BK, Zhang H, Becker A, Matei I, Huang Y, Costa-Silva B, et al. Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res. 2014; 24: 766-9. doi: 10.1038/cr.2014.44 PMID: 24710597
25. Lodes MJ, Caraballo M, Suciu D, Munro S, Kumar A, Anderson B. Detection of cancer with serum miRNAs on an oligonucleotide microarray. PLoS One. 2009; 4: e6229. doi: 10.1371/journal.pone.0006229 PMID: 19597549
26. Huebner AR, Somparn P, Benjachat T, Leelahavanichkul A, Avihingsanon Y, Fenton RA, et al. Exosomes in urine biomarker discovery. Adv Exp Med Biol. 2015; 845: 43-58. doi: 10.1007/978-94-017-9523-4-5 PMID: 25355568
27. Mitchell PJ, Welton J, Staffurth J, Court J, Mason MD, Tabi Z, et al. Can urinary exosomes act as treatment response markers in prostate cancer? J Transl Med. 2009; 7: 4. doi: 10.1186/1479-5876-7-4 PMID: 19138409
28. Nilsson J, Skog J, Nordstrand A, Baranov V, Mincheva-Nilsson L, Breakefield XO, et al. Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer. Br J Cancer. 2009; 100: 1603-7. doi: 10.1038/sj.bjc.6605058 PMID: 19401683
29. Zhou H, Cheruvanky A, Hu X, Matsumoto T, Hiramatsu N, Cho ME, et al. Urinary exosomal transcription factors, a new class of biomarkers for renal disease. Kidney Int. 2008; 74: 613-21. doi: 10.1038/ki. 2008.206 PMID: 18509321
30. Moon P-G, Lee J-E, You S, Kim T-K, Cho J-H, Kim I-S, et al. Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy. Proteomics. 2011; 11: 2459-75. doi: 10.1002/pmic.201000443 PMID: 21595033
31. Barutta F, Tricarico M, Corbelli A, Annaratone L, Pinach S, Grimaldi S, et al. Urinary exosomal micro-RNAs in incipient diabetic nephropathy. PLoS One. 2013; 8: e73798. doi: 10.1371/journal.pone. 0073798 PMID: 24223694
32. Dear JW, Street JM, Bailey MA. Urinary exosomes: a reservoir for biomarker discovery and potential mediators of intrarenal signalling. Proteomics. 2013; 13: 1572-80. doi: 10.1002/pmic.201200285 PMID: 23129434
33. Alvarez S, Suazo C, Boltansky A, Ursu M, Carvajal D, Innocenti G, et al. Urinary exosomes as a source of kidney dysfunction biomarker in renal transplantation. Transplant Proc. 2013; 45: 3719-23. doi:10.1016/j.transproceed.2013.08.079 PMID: 24315007
34. Beckham CJ, Olsen J, Yin PN, Wu CH, Ting HJ, Hagen FK, et al. Bladder cancer exosomes contain EDIL-3/Del1 and facilitate cancer progression. J Urol. 2014; 192: 583-592. doi: 10.1016/j.juro.2014.02. 035 PMID: 24530986
35. Armstrong DA, Green BB, Seigne JD, Schned AR, Marsit CJ. MicroRNA molecular profiling from matched tumor and bio-fluids in bladder cancer. Mol Cancer. 2015; 14: 194. doi: 10.1186/s12943-015-0466-2 PMID: 26576778
36. Matullo G, Naccarati A, Pardini B. microRNA expression profiling in bladder cancer: The challenge of Next Generation Sequencing in tissues and biofluids. Int J Cancer. 2015; doi: 10.1002/ijc.29895
37. Street JM, Yuen PST, Star RA. Bioactive exosomes: possibilities for diagnosis and management of bladder cancer. J Urol. 2014; 192: 297-8. doi: 10.1016/j.juro.2014.05.050 PMID: 24837807
38. Eissa S, Matboli M, Essawy NOE, Kotb YM. Integrative functional genetic-epigenetic approach for selecting genes as urine biomarkers for bladder cancer diagnosis. Tumour Biol. 2015; doi: 10.1007/ s13277-015-3722-6
39. Eissa S, Matboli M, Essawy NOE, Shehta M, Kotb YM. Rapid detection of urinary long non-coding RNA urothelial carcinoma associated one using a PCR-free nanoparticle-based assay. Biomarkers. 2015; 20: 212-7. doi: 10.3109/1354750X.2015.1062918 PMID: 26161701
40. Zhou H, Yuen PST, Pisitkun T, Gonzales PA, Yasuda H, Dear JW, et al. Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery. Kidney Int. 2006; 69: 1471-6. doi: 10.1038/sj.ki.5000273 PMID: 16501490
41. Qi P, Du X. The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod Pathol. 2013; 26: 155-165. doi: 10.1038/modpathol.2012.160 PMID: 22996375
42. Wang J, Zhou Y, Lu J, Sun Y, Xiao H, Liu M, et al. Combined detection of serum exosomal miR-21 and HOTAIR as diagnostic and prognostic biomarkers for laryngeal squamous cell carcinoma. Med Oncol. 2014; 31: 148. doi: 10.1007/s12032-014-0148-8 PMID: 25099764
43. Yang Z, Zhou L, Wu LM, Lai MC, Xie HY, Zhang F, et al. Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann Surg Oncol. 2011; 18: 1243-1250. doi: 10.1245/s10434-011-1581-y PMID: 21327457
44. Zhang ZZ, Shen ZY, Shen YY, Zhao EH, Wang M, Wang CJ, et al. HOTAIR Long Noncoding RNA Promotes Gastric Cancer Metastasis through Suppression of Poly r(C)-Binding Protein (PCBP) Mol Cancer Ther. 2015; 14: 1162-1170. doi: 10.1158/1535-7163.MCT-14-0695 PMID: 25612617
45. Yan T-H, Lu S-W, Huang Y-Q, Que G-B, Chen J-H, Chen Y-P, et al. Upregulation of the long noncoding RNA HOTAIR predicts recurrence in stage Ta/T1 bladder cancer. Tumour Biol. 2014; 35: 10249-57. doi: 10.1007/s13277-014-2344-8 PMID: 25030736
46. Martínez-Fernández M, Feber A, Dueñas M, Segovia C, Rubio C, Fernandez M, et al. Analysis of the Polycomb-related lncRNAs HOTAIR and ANRIL in bladder cancer. Clin Epigenetics. 2015; 7: 109. doi: 10.1186/s13148-015-0141-x PMID: 26457124
47. Sun X, Du P, Yuan W, Du Z, Yu M, Yu X, et al. Long non-coding RNA HOTAIR regulates cyclin J via inhibition of microRNA-205 expression in bladder cancer. Cell Death Dis. 2015; 6: e1907. doi: 10.1038/ cddis.2015.269 PMID: 26469956
48. Hajjari M, Salavaty A. HOTAIR: an oncogenic long non-coding RNA in different cancers. Cancer Biol Med. 2015; 12: 1-9. doi: 10.7497/j.issn.2095-3941.2015.0006 PMID: 25859406
49. Yang Q-Q, Deng Y-F. Long non-coding RNAs as novel biomarkers and therapeutic targets in head and neck cancers. Int J Clin Exp Pathol. 2014; 7: 1286-92. PMID: 24817925
50. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc. 2012; 7: 562-578. doi: 10.1038/nprot.2012.016 PMID: 22383036
51. Xu Z-Y, Yu Q-M, Du Y-A, Yang L-T, Dong R-Z, Huang L, et al. Knockdown of long non-coding RNA HOTAIR suppresses tumor invasion and reverses epithelial-mesenchymal transition in gastric cancer. Int J Biol Sci. 2013; 9: 587-97. doi: 10.7150/ijbs.6339 PMID: 23847441
52. Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002; 2: 569-579. doi: 10.1038/nri855 PMID: 12154376
53. Liang CC, Park AY, Guan JL. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc. 2007; 2: 329-333. doi: 10.1038/nprot.2007.30 PMID: 17406593
54. Albini A, Benelli R. The chemoinvasion assay: a method to assess tumor and endothelial cell invasion and its modulation. Nat Protoc. 2007; 2: 504-511. doi: 10.1038/nprot.2006.466 PMID: 17406614
55. Ravi M, Paramesh V, Kaviya SR, Anuradha E, Solomon FD. 3D cell culture systems: advantages and applications. J Cell Physiol. 2015; 230: 16-26. doi: 10.1002/jcp.24683 PMID: 24912145
56. Vinci M, Gowan S, Boxall F, Patterson L, Zimmermann M, Court W, et al. Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biol. 2012; 10: 29. doi: 10.1186/1741-7007-10-29 PMID: 22439642
57. Jenjaroenpun P, Kremenska Y, Nair VM, Kremenskoy M, Joseph B, Kurochkin I V. Characterization of RNA in exosomes secreted by human breast cancer cell lines using next-generation sequencing. PeerJ. 2013; 1: e201. doi: 10.7717/peerj.201 PMID: 24255815
58. Andersen CL, Jensen JL, Ørntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004; 64: 5245-50. doi: 10.1158/0008-5472.CAN-04-0496 PMID: 15289330
59. Zhao H, Zhang X, Frazao JB, Condino-Neto A, Newburger PE. HOX antisense lincRNA HOXA-AS2 is an apoptosis repressor in all trans retinoic acid treated NB4 promyelocytic leukemia cells. J Cell Biochem. 2013; 114: 2375-2383. doi: 10.1002/jcb.24586 PMID: 23649634
60. Hou P, Zhao Y, Li Z, Yao R, Ma M, Gao Y, et al. LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis. Cell Death Dis. 2014; 5: e1287. doi: 10.1038/cddis.2014.249 PMID: 24922071
61. Ying L, Chen Q, Wang Y, Zhou Z, Huang Y, Qiu F. Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition. Mol Biosyst. 2012; 8: 2289-2294. doi: 10.1039/c2mb25070e PMID: 22722759
62. Han Y, Liu Y, Nie L, Gui Y, Cai Z. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder. Urology. 2013; 81: 209 e1-7. doi: 10.1016/j.urology.2012.08.044 PMID: 23153939
63. Zhu H, Li X, Song Y, Zhang P, Xiao Y, Xing Y. Long non-coding RNA ANRIL is up-regulated in bladder cancer and regulates bladder cancer cell proliferation and apoptosis through the intrinsic pathway. Biochem Biophys Res Commun. 2015; 467: 223-228. doi: 10.1016/j.bbrc.2015.10.002 PMID: 26449463
64. Duan R, Han L, Wang Q, Wei J, Chen L, Zhang J, et al. HOXA13 is a potential GBM diagnostic marker and promotes glioma invasion by activating the Wnt and TGF-beta pathways. Oncotarget. 2015; 6: 27778-27793. doi: 10.18632/oncotarget.4813 PMID: 26356815
65. Slawek S, Szmyt K, Fularz M, Dziudzia J, Boruczkowski M, Sikora J, et al. Pluripotency transcription factors in lung cancer - a review. Tumour Biol. 2015; doi: 10.1007/s13277-015-4407-x
66. Heubach J, Monsior J, Deenen R, Niegisch G, Szarvas T, Niedworok C, et al. The long noncoding RNA HOTAIR has tissue and cell type-dependent effects on HOX gene expression and phenotype of urothelial cancer cells. Mol Cancer. 2015; 14: 108. doi: 10.1186/s12943-015-0371-8 PMID: 25994132
67. Chen F-J, Sun M, Li S-Q, Wu Q-Q, Ji L, Liu Z-L, et al. Upregulation of the long non-coding RNA HOTAIR promotes esophageal squamous cell carcinoma metastasis and poor prognosis. Mol Carcinog. 2013; 52: 908-15. doi: 10.1002/mc.21944 PMID: 24151120
68. Kogo R, Shimamura T, Mimori K, Kawahara K, Imoto S, Sudo T, et al. Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 2011; 71: 6320-6326. doi: 10.1158/0008-5472.CAN-11-1021 PMID: 21862635
69. Liu Y, Luo F, Xu Y, Wang B, Zhao Y, Xu W, et al. Epithelial-mesenchymal transition and cancer stem cells, mediated by a long non-coding RNA, HOTAIR, are involved in cell malignant transformation induced by cigarette smoke extract. Toxicol Appl Pharmacol. 2015; 282: 9-19. doi: 10.1016/j.taap. 2014.10.022 PMID: 25447409
70. Wu Z-H, Wang X-L, Tang H-M, Jiang T, Chen J, Lu S, et al. Long non-coding RNA HOTAIR is a powerful predictor of metastasis and poor prognosis and is associated with epithelial-mesenchymal transition in colon cancer. Oncol Rep. 2014; 32: 395-402. doi: 10.3892/or.2014.3186 PMID: 24840737
71. Li S, Qin X, Li Y, Zhang X, Niu R, Zhang H, et al. MiR-133a suppresses the migration and invasion of esophageal cancer cells by targeting the EMT regulator SOX4. Am J Transl Res. 2015; 7: 1390-403. PMID: 26396670
72. Zhou L, Shi L, Guo H, Yao X. MYSM-1 suppresses migration and invasion in renal carcinoma through inhibiting epithelial-mesenchymal transition. Tumour Biol. 2015; doi: 10.1007/s13277-015-4138-z
73. Rieger KM, Little AF, Swart JM, KastrinakisWV, Fitzgerald JM, Hess DT, et al. Human bladder carcinoma cell lines as indicators of oncogenic change relevant to urothelial neoplastic progression. Br J Cancer. 1995; 72: 683-90. PMID: 7669581
74. Matsui Y, Assi K, Ogawa O, Raven PA, Dedhar S, Gleave ME, et al. The importance of integrin-linked kinase in the regulation of bladder cancer invasion. Int J Cancer. 2012; 130: 521-31. doi: 10.1002/ijc. 26008 PMID: 21351095
75. Seiki M. Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. Cancer Lett. 2003; 194: 1-11. PMID: 12706853
76. Balda MS, Garrett MD, Matter K. The ZO-1-associated Y-box factor ZONAB regulates epithelial cell proliferation and cell density. J Cell Biol. 2003; 160: 423-32. doi: 10.1083/jcb.200210020 PMID: 12566432
77. Kladi-Skandali A, Michaelidou K, Scorilas A, Mavridis K. Long Noncoding RNAs in Digestive System Malignancies: A Novel Class of Cancer Biomarkers and Therapeutic Targets? Gastroenterol Res Pr. 2015; 2015: 319861. doi: 10.1155/2015/319861
78. Zhang L, Song X, Wang X, Xie Y, Wang Z, Xu Y, et al. Circulating DNA of HOTAIR in serum is a novel biomarker for breast cancer. Breast Cancer Res Treat. 2015; 152: 199-208. doi: 10.1007/s10549-015-3431-2 PMID: 26033707
79. Real FX, Boutros PC, Malats N. Next-generation sequencing of urologic cancers: next is now. Eur Urol. 2014; 66: 4-7. doi: 10.1016/j.eururo.2014.03.028 PMID: 24731787
80. Li Q, Shao Y, Zhang X, Zheng T, Miao M, Qin L, et al. Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer. Tumour Biol. 2015; 36: 2007-12. doi:10.1007/s13277-014-2807-y PMID: 25391424
81. Kishikawa T. Circulating RNAs as new biomarkers for detecting pancreatic cancer. World J Gastroenterol. 2015; 21: 8527. doi: 10.3748/wjg.v21.i28.8527 PMID: 26229396
82. Morrissy AS, Morin RD, Delaney A, Zeng T, McDonald H, Jones S, et al. Next-generation tag sequencing for cancer gene expression profiling. Genome Res. 2009; 19: 1825-35. doi: 10.1101/gr.094482.109 PMID: 19541910
83. Mardis ER, Wilson RK. Cancer genome sequencing: a review. Hum Mol Genet. 2009; 18: R163-8. doi: 10.1093/hmg/ddp396 PMID: 19808792
84. Cieslik M, Chugh R, Wu Y-M, Wu M, Brennan C, Lonigro R, et al. The use of exome capture RNA-seq for highly degraded RNA with application to clinical cancer sequencing. Genome Res. 2015; 25: 1372-81. doi: 10.1101/gr.189621.115 PMID: 26253700
85. Arscott WT, Camphausen KA. Analysis of urinary exosomes to identify new markers of non-small-cell lung cancer. Biomark Med. 2011; 5: 822. PMID: 22207914
86. Duijvesz D, Versluis CYL, van der Fels CAM, Vredenbregt-van den Berg MS, Leivo J, Peltola MT, et al. Immuno-based detection of extracellular vesicles in urine as diagnostic marker for prostate cancer. Int J Cancer. 2015; 137: 2869-78. doi: 10.1002/ijc.29664 PMID: 26139298
87. Dijkstra S, Birker IL, Smit FP, Leyten GHJM, de Reijke TM, van Oort IM, et al. Prostate cancer biomarker profiles in urinary sediments and exosomes. J Urol. 2014; 191: 1132-8. doi: 10.1016/j.juro. 2013.11.001 PMID: 24211598
88. Erdbrügger U, Le TH. Extracellular Vesicles in Renal Diseases: More than Novel Biomarkers? J Am Soc Nephrol. 2015; doi: 10.1681/ASN.2015010074
89. Borges FT, Reis LA, Schor N. Extracellular vesicles: structure, function, and potential clinical uses in renal diseases. Braz J Med Biol Res. 2013; 46: 824-30. doi: 10.1590/1414-431X20132964 PMID: 24141609
90. Anderson HC, Mulhall D, Garimella R. Role of extracellular membrane vesicles in the pathogenesis of various diseases, including cancer, renal diseases, atherosclerosis, and arthritis. Lab Invest. 2010; 90: 1549-57. doi: 10.1038/labinvest.2010.152 PMID: 20805791
91. Gámez-Valero A, Lozano-Ramos SI, Bancu I, Lauzurica-Valdemoros R, Borràs FE. Urinary extracellular vesicles as source of biomarkers in kidney diseases. Front Immunol. 2015; 6: 6. doi: 10.3389/fimmu. 2015.00006 PMID: 25688242
92. Lee H, Han KH, Lee SE, Kim SH, Kang HG, Cheong H Il. Urinary exosomal WT1 in childhood nephrotic syndrome. Pediatr Nephrol. 2012; 27: 317-20.